0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Endocrinology > Diabetes

Buy Now

Diabetic Renal-Retinal Syndrome - 21st Century Management Now (Paperback, Softcover reprint of the original 1st ed. 1998) Loot Price: R4,492
Discovery Miles 44 920
Diabetic Renal-Retinal Syndrome - 21st Century Management Now (Paperback, Softcover reprint of the original 1st ed. 1998): E.A....

Diabetic Renal-Retinal Syndrome - 21st Century Management Now (Paperback, Softcover reprint of the original 1st ed. 1998)

E.A. Friedman, Francis A. L'Esperance Jr

 (sign in to rate)
Loot Price R4,492 Discovery Miles 44 920 | Repayment Terms: R421 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

After a decade or longer, approximately one-third of individuals with either type 1 or type 2 diabetes commence a downhill course in which decreasing renal function and failing vision define a Renal-Retinal Syndrome, dominating all aspects of life and presaging early death. Only a generation ago, survival after onset of end-stage renal disease (ESRD) in diabetes was limited because rehabilitation was preempted by blindness, limb amputation, stroke, and heart disease. By 1998, however, team management has improved the outlook, with preserved sight and return to work and home responsibilities, usually for a decade or longer, following kidney transplantation and laser photocoagulation. Recognition of the critical requirement for blood pressure regulation and metabolic control are central themes in management. In this unique book, the accomplishments of ophthalmologists, nephrologists, diabetologists, transplant surgeons, and basic scientists are blended into a strategic approach that may be readily applied by all those caring for diabetic patients. Each of twenty-one presentations suitable for primary care physicians, as well as for subspecialists concerned with macrovascular and microvascular complications of diabetes, is placed in perspective by an introductory editorial analysis. Promising near-term innovative therapies, including insertion of genetically engineered beta cells or polymer-coated islets of Langerhans, interdiction of kinins that promote retinal angiogenesis, and prevention of synthesis of advanced glycosylated endproducts (AGEs), are presented in detail. While comprehensive care of diabetic patients reflects multiple incremental advances that in sum afford major benefit, this text envisions further remarkable changes likely to suppress and possibly entirely prevent the Diabetic Renal-Retinal Syndrome.

General

Imprint: Springer
Country of origin: Netherlands
Release date: October 2012
First published: 1998
Editors: E.A. Friedman • Francis A. L'Esperance Jr
Dimensions: 240 x 160 x 20mm (L x W x T)
Format: Paperback
Pages: 284
Edition: Softcover reprint of the original 1st ed. 1998
ISBN-13: 978-9401060837
Categories: Books > Medicine > Clinical & internal medicine > Ophthalmology
Books > Medicine > Clinical & internal medicine > Endocrinology > Diabetes
Books > Medicine > Clinical & internal medicine > Renal medicine > General
LSN: 9401060835
Barcode: 9789401060837

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners